Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHKW5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,242
Award facts
- Contract value 100% obligated
- $87,242.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $87,242.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract, issued on January 22, 2026, with an ultimate completion date of February 12, 2026, contains no set-aside designation, indicating competitive procurement. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and serve as the sole contractor on this delivery order with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent contract, valued at $499.999 billion with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceuticals and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FHKW5?
SPE2DR26FHKW5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FHKW5 worth?
The government has obligated $87,242 on SPE2DR26FHKW5.
Is contract SPE2DR26FHKW5 an order under another contract?
Yes. SPE2DR26FHKW5 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKW5 competed?
The extent of competition for SPE2DR26FHKW5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award